Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.5 CNY -3.46% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cash Equivalents
ÂĄ3.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cash Equivalents
ÂĄ2.5B
CAGR 3-Years
90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
32.63 CNY
Undervaluation 34%
Intrinsic Value
Price

See Also

Back to Top